ACell Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Columbia, MD USA
Total Funding:N/A
Industry:Medical Equip
Founded:2002
Lead Investor(s):N/A

Estimated Revenue & Financials

  • ACell's estimated annual revenue is currently $121M per year.
  • ACell received $6.0M in venture funding in March 2004.
  • ACell's estimated revenue per employee is $251,000

Employee Data

  • ACell has 482 Employees.
  • ACell grew their employee count by 1% last year.
  • ACell currently has 1 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
$6.3M25N/AN/A-N/A
#2
$327.8M1306N/AN/A-N/A
#3
$28.6M1143%N/A-N/A
#4
$50.7M202-22%N/A-N/A
#5
$4.8M19N/AN/A-N/A
#6
$111.7M445N/AN/A-N/A
#7
$16.1M6436%N/A-N/A
#8
$13.6M54-5%N/A-N/A
#9
$121M4821%N/A-N/A
#10
$14.3M57-19%N/A-N/A
Missing a competitor? Contribute!?
Submit

Founded in 2002 and headquartered in Columbia, Maryland, with more than 300 employees in the United States, ACell, Inc. is a leading developer, manufacturer, and marketer of next-generation regenerative medicine products. ACell offers their regenerative medicine products through the development and commercialization of unique extracellular matrix medical devices to repair and remodel damaged tissues and organs in a broad range of surgical procedures. ACell medical devices are cleared for a variety of indications and are marketed under the brand name "MatriStem." A privately held company, ACell produces MatriStem at its full scale manufacturing facilities in Columbia, MD and Lafayette, IN, and markets its products to physicians in the U.S. through a national direct sales force.

keywords:Biotechnology,Healthcare,Medical Devices,Pharmaceuticals

482

Number of Employees

$121M

Revenue (est)

1

Current Jobs

1%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

B2B

Type

ACell News

09/03/2019 - ACell and Southmedic Announce Canadian Launch of Gentrix ...

Line of Reinforcement Devices for Hernia and Abdominal Wall Repair to be Introduced at Canadian Surgery Forum. COLUMBIA, Md., Sept.

09/05/2019 - ACell Launches Gentrix Hiatal at Society of Laparoendoscopic ...

5, 2019 /PRNewswire/ -- ACell, Inc. today announced the launch of their new product, Gentrix® Hiatal at the 2019 Society of Laparoendoscopic ...

09/03/2019 - The Fiend's Hell in a Cell match opponent revealed (spoiler)

WWE Hell in a Cell 2019 will take place at the Golden 1 Center. Last week, they tweeted that Bray Wyatt will confront either Seth Rollins or ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
$105.6M503N/AN/A-N/A
#2
$138.5M513N/AN/A-N/A
#3
$94.7M526N/AN/A-N/A
#4
$96.1M534N/AN/A-N/A
#5
$100.1M556N/AN/A-N/A

ACell Funding

DateAmountRoundLead InvestorsReference
2004-03-23$6.0MFirstArticle

ACell Executive Hires

DateNameTitleReference
2016-01-12Patrick McBrayerPresident/CEOArticle
2016-08-23Brad AdamsVP SalesArticle
2018-05-09Nino PionatiVP International/Business DevelopmentArticle